Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Diagn Microbiol Infect Dis. 2016 Jul 27;86(3):322–326. doi: 10.1016/j.diagmicrobio.2016.07.026

Table 5.

Comparison of the 10 subjects with erythema migrans who had an FSS-11 score of ≥ 4 with the other 41 subjects.

Characteristic FSS-11 ≥ 4 n=10 FSS-11 < 4 n=41 P value
% male 50 68.3 0.30
Mean age ± SD in years 46.3 ± 17.6 50.6 ± 15.1 0.49
Mean ± SD body mass index 24.0 ± 13.5 25.5 ± 3.9 0.25
% with symptoms at study entry 100 70.7 0.09
Mean number of symptoms ± SD 7.5 ± 3.0 2.2 ± 1.26 < 0.001
% with multiple erythema migrans skin lesions 60 36.6 0.28
Mean duration ± SD of erythema migrans skin lesion in days 8.9 ± 7.1 7.6 ± 5.2 0.60
Mean area ± SD of largest skin lesion in square cm* 187.7 ± 256.9 177.9 ± 188.4 0.91
% with reactive C6 Lyme serology** 80 61 0.46
Mean ± SD C6 ELISA value 5.0 ± 3.5 4.1 ± 3.8 0.50
% with co-infection 10.0 7.3 1.0
*

Area defined as the maximum width times the maximum length

**

Test result was positive or equivocal